MBOT - Microbot Medical Inc.
Microbot Medical Inc. operates as a pre-clinical stage medical device company, concentrating its efforts on the research, design, and development of robotic instruments for endoluminal surgery, specifically targeting the field of minimally invasive procedures. Leveraging its proprietary micro-robotic technologies, which include ViRob, TipCAT, CardioSert, and Liberty, the company is actively developing several key products.
As of Jun 30, 2026: spot at $1.96, ATM IV 178.7%, max pain $2.00, net GEX $8.8K.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Market Cap
- $80.7M
- Beta
- 1.03
- 52-Week Range
- 1.6-4.67
- CEO
- Harel Gadot
- Employees
- 20
- IPO Date
- Mar 25, 1992
- Exchange
- NASDAQ
What MBOT Looks Like to Options Traders Today
IV rank of 60.1% sits near the 1-year median, where strategy choice depends on directional conviction and the event calendar rather than vol regime alone; positive net gamma exposure ($8.8K) means dealers hedge against trend, damping realized volatility and biasing price toward heavy-OI strikes; the 25-delta skew (0.059) prices calls richer than puts, often reflecting upside speculation or squeeze risk.
What This Page Covers
The MBOT overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked MBOT overview questions
- What is MBOT?
- MBOT is the ticker symbol for Microbot Medical Inc., a listed security. Microbot Medical Inc. operates as a pre-clinical stage medical device company, concentrating its efforts on the research, design, and development of robotic instruments for endoluminal surgery, specifically targeting the field of minimally invasive procedures. Listed on NASDAQ. MBOT is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What does the MBOT options snapshot look like today?
- As of Jun 30, 2026, the MBOT options snapshot shows spot at $1.96, ATM IV 178.7%, IV rank 60.1%, max pain $2.00, net GEX $8.8K, expected move 51.23%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are MBOT's key statistics?
- Microbot Medical Inc. (MBOT) carries a market capitalization of $80.7M, beta of 1.03 relative to the broader market, 52-week range of 1.6-4.67. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does MBOT belong to?
- Microbot Medical Inc. operates in the Healthcare sector, in the Medical - Instruments & Supplies industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare MBOT's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the MBOT data on this page?
- The options snapshot above is dated Jun 30, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).